High-Risk Ewing Sarcoma: It Is Time to Break the Ceiling

被引：4
|
作者：
DuBois, Steven G. [1 ]
Gupta, Abha A. [2 ,3 ]
Palmerini, Emanuela [4 ,5 ]
机构：
[1] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA
[2] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] IRCCS Ist Ortoped Rizzoli, Osteoncol Bone & Soft Tissue Sarcomas & Innovat T, Bologna, Italy
[5] Bologna Univ, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 21期
关键词：
D O I：
10.1200/JCO.22.00449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2288 / +
页数：4
相关论文
共 50 条
  • [21] Treatment of patients with high-risk axial and pelvic Ewing's sarcoma. A single-centre experience
    Dolgopolov, I.
    Pimenov, R.
    Boyarshinov, V.
    Subbotina, N.
    Visochin, I.
    Siegel, S.
    Mentkevich, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S267 - S267
  • [22] TREATMENT OF HIGH RISK EWING'S SARCOMA WITH HDC AND SCT
    Ozaydin, S.
    Ozturk, M.
    Karadurmus, N.
    Erdem, G.
    Arpaci, F.
    LEUKEMIA RESEARCH, 2014, 38 : S50 - S51
  • [23] TREATMENT OF PATIENTS WITH HIGH-RISK AXIAL AND PELVIC EWING'S SARCOMA (ES). A SINGLE-INSTITUTION EXPERIENCE
    Pimenov, Roman
    Dolgopolov, Igor
    Subbotina, Natalia
    Boyarshinov, Vasily
    Mentkevich, Georgy
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S103 - S103
  • [24] Prediction of high-risk Ewing's sarcoma by gene expression profiling (vol 23, pg 8997, 2004)
    Ohali, A
    Avigad, S
    Zaizov, R
    Ophir, R
    Horn-Saban, S
    Cohen, IJ
    Meller, I
    Kollender, Y
    Issakov, J
    Yaniv, I
    ONCOGENE, 2005, 24 (26) : 4319 - 4319
  • [25] High-dose chemotherapy in patients with high-risk Ewing's sarcoma of pelvis. A single-centre experience
    Dolgopolov, I.
    Boyarshinov, V.
    Pimenov, R.
    Subbotina, N.
    Visotchin, I.
    Siegel, S.
    Mentkevich, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S226 - S226
  • [26] THE TREATMENT OF CHILDREN WITH HIGH-RISK SYNOVIAL SARCOMA
    Shvarova, Anna
    Ivanova, Nadeghda
    Ravshanova, Rano
    Kajumov, Rahmanali
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 816 - 816
  • [27] Treatment results for patients with high-risk Ewing's Sarcoma family tumors (ES). Single-institute experience
    Ptushkina, E
    Dolgopolov, I
    Ivanova, N
    Petrosian, A
    Andreeva, L
    Msheidze, D
    Ravshanova, R
    Siegel, S
    Mentkevitch, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S334 - S334
  • [28] G-CSF-primed peripheral blood progenitor cells (PBPC) support in high-risk Ewing sarcoma of childhood
    Prete, A
    Rosito, P
    Alvisi, P
    Rondelli, R
    Melchionda, F
    Magrini, E
    Pession, A
    BONE MARROW TRANSPLANTATION, 1998, 22 : S21 - S23
  • [29] Using genome-wide CRISPR screening to develop novel combination therapies for high-risk Ewing's sarcoma
    Ravindrarajah, Daenikka
    Krishan, Sukriti
    Simpson, Kayleen
    Gulati, Twishi
    Cheung, Belamy B.
    Marshall, Glenn M.
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Experience in high-dose chemotherapy with peripheral stem cell rescue and biotherapy for young adults with high-risk Ewing/PNET sarcoma
    Petrovitch, S.
    Zhavrid, E.
    Aleinikova, O.
    Kiselev, L.
    Strongin, Y. U.
    Baranau, Y.
    Demidovich, E.
    Minailo, I.
    Belotserkovskaya, M.
    Stuk, N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 598 - 598
12345